the role of molecular chaperones in α-synuclein-related diseases
the role of molecular chaperones in α-synuclein-related diseases
批准号:
15590887
负责人:
KAWAMOTO Yasuhiro
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2005
中文摘要
点击翻译按钮获取中文摘要
英文摘要
14-3-3 proteins, a novel type of molecular chaperons, recognizes the phosphoserine-containing motifs of several target proteins, and regulates various types of signal transduction pathways. We have already reported that 14-3-3 immunoreactivity was localized to the α-synuclein-containing inclusins in brains with Parkinso's disease and multiple system atrophy. We then examined the brains and spinal cords of human α-synuclein (A53T) transgenic mice, and found the immunohistochemical colocalization of α-synuclein and 14-3-3 proteins. We also observed the increased immunoreactivities for some heat shock proteins in brains with synucleinopathies. Furthermore, we performed immunohistochemical studies on 14-3-3 proteins using autopsied spinal cord from patients with amyotrophic lateral sclerosis (ALS), and found 14-3-3 immunoreactivity in the Lewy body-like hyaline inclusions from both sporadic and familial ALS cases. We also observed that 14-3-3 immunoreactivity was localized to the α-synuclein-containing inclusinsin in the anterior horn cells from human SOD1(G93T) trausgenic mice. Moreover, we found the enhanced astroglial immunoexpression of 14-3-3 in the demyelinated lesions from patients with multiple sclerosis and progressive multifocal leukoencephalopathy, and in the cortical and subcortical lesions from patients with Creutzfeldt-Jakob disease, and in the ischemic white matter lesions from Binswanger's disease cases. These data suggest that 14-3-3 proteins may play an important role in the formation of several types of inclusions in brains with neurodegenerative diseases, and that 14-3-3 proteins may be induced in astrocytes under various kinds of pathological conditions, including demyelination, inflammation, and ischemia, and may be associated with the formation of astrogliosis.
期刊论文(35)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
14-3-3 proteins in Lewy body-like hyaline inclusions in a patients with a two-base pair deletion in the Cu/Zn superoxide dismutaze (SOD1) gene
Cu/Zn 超氧化物歧化酶 (SOD1) 基因中存在两碱基对缺失的患者中路易体样透明包涵体中的 14-3-3 蛋白
DOI:
--
发表时间:
2005
期刊:
Acta Nueropathologica 110
影响因子:
--
作者:
[Y.Kawamoto et al., Y.Kawamoto, Y.Kawamoto et al.]
通讯作者:
Y.Kawamoto et al.
DOI:
10.1007/s00401-003-0785-z
发表时间:
2004-02-01
期刊:
ACTA NEUROPATHOLOGICA
影响因子:
12.7
作者:
[Kawamoto, Y, Akiguchi, I, Budka, H]
通讯作者:
Budka, H
DOI:
10.1007/s00401-004-0892-5
发表时间:
2004-10-01
期刊:
ACTA NEUROPATHOLOGICA
影响因子:
12.7
作者:
[Kawamoto, Y, Akiguchi, I, Budka, H]
通讯作者:
Budka, H
14-3-3 proteins in Lewy body-like in a patients with a two-base pair deletion in the Cu/Zn superoxide dismutaze (SOD1) gene
Cu/Zn 超氧化物歧化酶 (SOD1) 基因中存在两个碱基对缺失的患者体内的 14-3-3 类路易体蛋白
DOI:
--
发表时间:
2005
期刊:
Acta Neuropathologica 110
影响因子:
--
作者:
[Y.Kawamoto et al., Y.Kawamoto, Y.Kawamoto et al., Y.Kawamoto et al.]
通讯作者:
Y.Kawamoto et al.
DOI:
10.1007/s00401-004-0923-2
发表时间:
2004-12-01
期刊:
ACTA NEUROPATHOLOGICA
影响因子:
12.7
作者:
[Kawamoto, Y, Akiguchi, I, Budka, H]
通讯作者:
Budka, H
共 11 条
Research on the role of Omi/HtrA2 in the abnormal mitochondria in patients with Parkinson's disease
-
批准号:22590930
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.5万
-
财政年份:2010
-
负责人:KAWAMOTO Yasuhiro
-
依托单位:
Studies on Development of High Productive Grazing System and Nitrogen Dynamics on Tropical-Subtropical Pasture
-
批准号:14560227
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:2002
-
负责人:KAWAMOTO Yasuhiro
-
依托单位:
PRODUCTION,CUMULATIVE PATTERN AND UTILIZATION OF PROTEIN FRACTIONATED IN TROPICAL FORAGE SPECIES.
-
批准号:06660340
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1994
-
负责人:KAWAMOTO Yasuhiro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ROS介导的α-synuclein/KLF9/PRB信号轴调控子宫内膜异位症孕激素抵抗的分子机制研究
-
批准号:2026JJ81255
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:冯力元
-
依托单位:
天麻20C通过抑制α-Synuclein聚集二次成核动力学过程发挥帕金森病治疗特色的机制研究
-
批准号:2025JJ60645
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:彭也
-
依托单位:
新型 DMC 结构类似物抗帕金森病中α
-synuclein 病理的作用机制研究
-
批准号:Z24H250003
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:张云龙
-
依托单位:
α-Synuclein 乳酸化修饰降低突触可塑性导致 POCD 的机制研究
-
批准号:24ZR1457700
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:张辉
-
依托单位:
脾脏巨噬细胞功能失调介导血源性α-synuclein异构体清除障碍在PD发病中的机制研究
-
批准号:82301430
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:袁心
-
依托单位:
利用非人灵长类模型研究帕金森病致病蛋白α-synuclein的生理功能
-
批准号:32370567
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:杨伟莉
-
依托单位:
囊泡基质蛋白Chromogranin A调控α-synuclein异常聚集及其在帕金森病早期发病机制中的研究
-
批准号:82371426
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:吴齐辉
-
依托单位:
α-Synuclein通过抑制STUB1/TFEB介导的自噬促进肥胖相关的子宫内膜容受性下降的作用及机制研究
-
批准号:82301896
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:何晔
-
依托单位:
基于天然双四氢呋喃型木脂素结构的靶向α-synuclein聚集抑制的抗帕金森病先导化合物的发现研究
-
批准号:82373766
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚胜
-
依托单位:
红细胞来源的α-synuclein蛋白在帕金森病中的作用研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:金旺盛
-
依托单位: